AMP Capital Investors Ltd reduced its stake in shares of Clorox Co (NYSE:CLX) by 34.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,239 shares of the company’s stock after selling 24,203 shares during the quarter. AMP Capital Investors Ltd’s holdings in Clorox were worth $6,903,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Macquarie Group Ltd. grew its stake in shares of Clorox by 437,400.0% during the second quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock valued at $236,688,000 after purchasing an additional 1,749,600 shares during the last quarter. Schroder Investment Management Group grew its stake in shares of Clorox by 57.0% during the second quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock valued at $201,641,000 after purchasing an additional 547,070 shares during the last quarter. Morgan Stanley grew its stake in shares of Clorox by 44.2% during the second quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock valued at $148,962,000 after purchasing an additional 337,621 shares during the last quarter. FMR LLC grew its stake in shares of Clorox by 201.0% during the second quarter. FMR LLC now owns 472,179 shares of the company’s stock valued at $63,863,000 after purchasing an additional 315,298 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale grew its stake in shares of Clorox by 110.5% during the third quarter. DekaBank Deutsche Girozentrale now owns 427,013 shares of the company’s stock valued at $61,991,000 after purchasing an additional 224,143 shares during the last quarter. 77.96% of the stock is currently owned by institutional investors and hedge funds.
In other Clorox news, CEO Benno O. Dorer sold 152,449 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $164.83, for a total value of $25,128,168.67. Following the transaction, the chief executive officer now directly owns 111,735 shares of the company’s stock, valued at $18,417,280.05. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 25,950 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $164.59, for a total transaction of $4,271,110.50. Following the completion of the transaction, the chief operating officer now directly owns 32,409 shares in the company, valued at $5,334,197.31. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 265,851 shares of company stock worth $43,238,681. Insiders own 1.40% of the company’s stock.
Several analysts have recently commented on the stock. Zacks Investment Research reissued a “sell” rating on shares of Clorox in a research note on Monday, November 12th. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. Bank of America reissued a “neutral” rating and set a $170.00 price target (up from $150.00) on shares of Clorox in a research note on Thursday. Wells Fargo & Co increased their price target on shares of Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 17th. Finally, Citigroup increased their price target on shares of Clorox from $149.00 to $153.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Five investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. Clorox has a consensus rating of “Hold” and an average target price of $144.93.
Shares of CLX stock opened at $162.47 on Friday. Clorox Co has a 52-week low of $113.57 and a 52-week high of $167.70. The company has a market capitalization of $20.89 billion, a price-to-earnings ratio of 25.95, a price-to-earnings-growth ratio of 4.02 and a beta of 0.30. The company has a current ratio of 1.07, a quick ratio of 0.65 and a debt-to-equity ratio of 3.38.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the firm earned $1.46 earnings per share. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. As a group, equities analysts anticipate that Clorox Co will post 6.31 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be paid a $0.96 dividend. The ex-dividend date is Tuesday, January 22nd. This represents a $3.84 dividend on an annualized basis and a yield of 2.36%. Clorox’s payout ratio is presently 61.34%.
COPYRIGHT VIOLATION NOTICE: “Clorox Co (CLX) Shares Sold by AMP Capital Investors Ltd” was reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/12/08/clorox-co-clx-shares-sold-by-amp-capital-investors-ltd.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Read More: Asset Allocation, Balancing Your Investments
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.